Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for Pharmazeutische Formulierungen mit Dapagliflozin-Propylenglycol-Hydrat
Details for 2012153939
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2012153939
Title / Product Name
Pharmazeutische Formulierungen mit Dapagliflozin-Propylenglycol-Hydrat
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2012153939
EP Publication Number
2508188
E-Number
1566053
Language
EN
PCT Number
Publication Date
10.10.2012 A
10.05.2023 B1
Registration Date
10.05.2023
AT Publication Date
15.05.2023
Application Date
21.03.2008
Registration Number
-
Priorities
22.03.2007
US
896286 P
IPC
A61K 31/70 20060101AFI20120903BHEP
Maximum Duration of Protection
21.03.2028
Owner
AstraZeneca AB
151 85 Södertälje
SE
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Kirchengasse 1)
1070 Wien
AT
Inventor
Bindra, Dilbir
1 Squibb Drive
New Brunswick, NJ 08903
US
Dali, Mandar V.
339 Tammy Lane
Bridgewater, New Jersey 08807
US
Parab, Prakash V.
1 Squibb Drive
New Brunswick, NJ 08903
US
Patel, Jatin M.
1 Squibb Drive
New Brunswick, NJ 08903
US
Tao, Li
1 Squibb Drive
New Brunswick, NJ 08903
US
Tejwani, Ravindra W.
1 Squibb Drive
New Brunswick, NJ 08903
US
Vatsaraj, Nipa
1 Squibb Drive
New Brunswick, NJ 08903
US
Wu, Yongmei
1 Squibb Drive
New Brunswick, NJ 08903
US
Information about Fees
Click here to load the fees